MNKD Q2 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$3M-135.1% margin

Operating Income

-$32M-1459.6% margin

Net Income

-$35M-1633.8% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-28.1%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$79M

Total Liabilities

$301M

Stockholders' Equity

-$221M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$3M	-$4M	+27.7%
Operating Income	-$32M	-$19M	-65.1%
Net Income	-$35M	-$30M	-18.0%